We have found 46589 results matching your criteria.
Please wait while we search...
  1. 1.
    General Material Information
  2. 2.
    PhysChem Properties
  3. 3.
    Occurrences
  4. 4.
    Organoleptic Properties
  5. 5.
    Suppliers
  6. 6.
    Potential Uses
  7. 7.
    Regulatory & Documentation
  8. 8.
    Safety Information
  9. 9.
    Other Information
  10. 10.
    Blenders & Components
  11. 11.
    Literature & References

artemisia dracunculus herb extract

General Material Information

Preferred name artemisia dracunculus herb extract
Trivial Name Tarragon, ext.
Short Description extract obtained from the whole herbs of the tarragon, artemisia dracunculus l., compositae
CAS Number 90131-45-6
ECHA Number 290-356-5
FDA UNII Search
FDA Mainterm 977029-81-4 ; TARRAGON EXTRACT (ARTEMISIA DRACUNCULUS L.)
Synonyms
  • artemisia aromatica herb extract
  • artemisia dracunculina herb extract
  • artemisia dracunculoides herb extract
  • artemisia dracunculoides var. dracunculina herb extract
  • artemisia dracunculus subsp. dracunculina herb extract
  • artemisia glauca herb extract
  • artemisia glauca var. megacephala herb extract
  • extract obtained from the whole herbs of the tarragon, artemisia dracunculus l., compositae
  • oligosporus dracunculus herb extract
  • tarragon extract
  • artemisia dracunculus l. herb extract
  • Tarragon, ext.
  • Artemisia dracunculus ext.

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar Start search
Google Books Start search
Google Patents Start search
Perfumer & Flavorists Start search
EU Patents Start search
PubMeb Start search
NCBI Start search

Literature & References

artemisia dracunculus l. herb extract
Pubchem (sid):135313669
Publications by PubMed
Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.
Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris.
Antinociceptive effect of the essential oil of tarragon (Artemisia dracunculus).
An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes.
Toxicological and mutagenic analysis of Artemisia dracunculus (tarragon) extract.
LC-PDA-ESI/MS identification of the phenolic components of three compositae spices: chamomile, tarragon, and Mexican arnica.
Essential oil of tarragon (Artemisia dracunculus) antibacterial activity on Staphylococcus aureus and Escherichia coli in culture media and Iranian white cheese.
Effective cytochrome P450 (CYP) inhibitors isolated from tarragon (Artemisia dracunculus).
Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioactives from Artemisia dracunculus L.
Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells.
Comparative evaluation of two different Artemisia dracunculus L. cultivars for blood sugar lowering effects in rats.
Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety.
Melanin biosynthesis inhibitors from Tarragon Artemisia dracunculus.
Qualitative variation of anti-diabetic compounds in different tarragon (Artemisia dracunculus L.) cytotypes.
Evaluation of PMI-5011, an ethanolic extract of Artemisia dracunculus L., on peripheral neuropathy in streptozotocin-diabetic mice.
Chemical composition of bioactive pressurized extracts of Romanian aromatic plants.
Survey of artemisinin production by diverse Artemisia species in northern Pakistan.
An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.
Carotenoid content of commonly consumed herbs and assessment of their bioaccessibility using an in vitro digestion model.
High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L.
Nematicidal activity of essential oils and volatiles derived from Portuguese aromatic flora against the pinewood nematode, Bursaphelenchus xylophilus.
Regulation of insulin action by an extract of Artemisia dracunculus L. in primary human skeletal muscle culture: a proteomics approach.
Efficient synthesis of flavanone glucuronides.
Acetylcholinesterase inhibitory activity and chemical composition of commercial essential oils.
Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L.
Heavy metals in selected edible vegetables and estimation of their daily intake in Sanandaj, Iran.
Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture.
Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans.
Screening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils.
Botanicals and the metabolic syndrome.
Comparative effects of Artemisia dracunculus, Satureja hortensis and Origanum majorana on inhibition of blood platelet adhesion, aggregation and secretion.
Inhibition of blood platelet adhesion, aggregation and secretion by Artemisia dracunculus leaves extracts.
Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line.
A source of almost pure methyl chavicol: volatile oil from the aerial parts of Tagetes lucida (Asteraceae) cultivated in Costa Rica.
A TLC bioautographic assay for the detection of nitrofurantoin resistance reversal compound.
Composition of the volatile fraction of Ocotea bofo Kunth (Lauraceae) calyces by GC-MS and NMR fingerprinting and its antimicrobial and antioxidant activity.
Screening antimicrobial activity of various extracts of Artemisia dracunculus L.
Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L.
Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus.
Determination of the chemical composition and antioxidant activity of the essential oil of Artemisia dracunculus and of the antifungal and antibacterial activities of Turkish Artemisia absinthium, A. dracunculus, Artemisia santonicum, and Artemisia spicigera essential oils.
[Occupational allergy to mugwort].
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity.
[Studies on the chemical constituents of the essential oil of Artemisia dracunculus].
Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil.
Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L. for use as a dietary supplement and in functional foods.
Antifungal 3-butylisocoumarins from Asteraceae-Anthemideae.
Antifungal constituents of the essential oil fraction of Artemisia dracunculus L. Var. dracunculus.
Alkamides from Artemisia dracunculus.
Evidence for an NIH shift as the origin of the apparently anomalous distribution of deuterium in estragole from Artemisia dracunculus.
Identification of benzodiazepines in Artemisia dracunculus and Solanum tuberosum rationalizing their endogenous formation in plant tissue.
Acetylenes and Other Constituents from Artemisia dracunculus.
Studies on the genotoxic properties of essential oils with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay.
Evaluation of traditional plant treatments for diabetes: studies in streptozotocin diabetic mice.
Natural inhibitors of complement. III. Inactivation of the complement cascade in vitro by vegetal spices (Ocimum basilicum, Artemisia dracunculus and Thymus vulgaris).
A study of four medicinal plant complexes of Mexico and adjacent United States.
[Studies on the accumulation and composition of the volatile oils of Satureja hortensis L., Satureja montana L. and Artemisia dracunculus L. during ontogenesis. 2. Changes in the content and composition of the volatile oil].
[Studies on the accumulation and composition of volatile oils in Satureja hortensis L., Satureja montana L. and Artemisia dracunculus L. during ontogenesis. 1. Review of literature, thin-layer and gas-chromatographic studies].

Other Information

FDA Substances Added to Food (formerly EAFUS):View
Export Tariff Code:1302.19.0000
Wikipedia:View

PhysChem Properties

Material listed in food chemical codex No

Organoleptic Properties

Odor Type: Herbal
tarragon
General comment At 100.00 %. tarragon
Flavor Type: Herbal
tarragon
General comment Tarragon

Occurrences

Safety Information

Safety information

Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Pictogram
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined

Safety in use information

Category:
flavor and fragrance agents
RIFM Fragrance Material Safety Assessment: Search
IFRA Code of Practice Notification of the 49th Amendment to the IFRA Code of Practice

Safety references

EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:2
artemisia dracunculus l. herb extract
Chemidplus:0090131456